Drug Research
Vaxart Announces Exclusive Worldwide License Agreement with Altesa Biosciences for its Vapendavir Antiviral Asset
Vaxart, Inc., a clinical-stage biotechnology company developing oral recombinant vaccines that are administered by tablet rather than by injection, announced that it has signed an exclusive worldwide licensing agreement with Altesa Biosciences, Inc. to allow Altesa to develop and...
Drug Research
Oxford researchers launch HIV vaccine trial
The University of Oxford has launched a Phase I trial of a novel mosaic vaccine targeting a ‘broad range’ of HIV variants.
The HIV-CORE 0052 trial, part of the European Aids Vaccine Initiative, will involve 13 healthy HIV-negative adults aged...
Drug Research
Roche & Mimetas collaborate to develop human disease models for drug development
Roche is teaming up with Mimetas, a provider of organ-on-chip-based disease model to develop human disease models to characterize novel compounds in inflammatory bowel disease (IBD) and hepatitis B virus infections (HBV).
The collaboration will see Mimetas developing tissue-based disease...
Drug Research
BioMed X and Merck KGaA, Darmstadt, Germany launch new research program in oncology
BioMed X, a leading independent research institute, announced the start of its eighth joint research program with Merck KGaA, Darmstadt, Germany. The new program will explore the role of extrachromosomal DNA in cancer and it will complement the research...
Drug Research
Recipharm signs Memorandum of Understanding (MOU) for the fill finish of vaccines and biotherapeutics in Morocco
Global contract development and manufacturing organisation (CDMO), Recipharm, has signed an MOU, along with His Majesty the King of Morocco, Mohammed VI, the Moroccan Government and a consortium of the country’s leading banks, that will see the company operate...
Drug Research
GSK and Alector to develop antibodies for neurodegenerative diseases
GlaxoSmithKline plc and Alector announced a strategic global collaboration for the development and commercialisation of two clinical-stage, potential first-in-class monoclonal antibodies (AL001 and AL101) designed to elevate progranulin (PGRN) levels. PGRN is a key regulator of immune activity in...
Drug Research
Pharma Majors Collaborate for Clinical Trial of Investigational Oral Anti-Viral Drug Molnupiravir for COVID-19
Cipla Limited, Dr. Reddy’s Laboratories Ltd., Emcure Pharmaceuticals Limited, Sun Pharmaceutical Industries Limited, and Torrent Pharmaceuticals Limited, announced that the five companies will collaborate for the clinical trial of the investigational oral anti-viral drug Molnupiravir for the treatment of...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read
